ENERCEUTICAL

Infectious Diseases and Host Cellular Energy

Looking beyond direct antimicrobial attack to the energetic capacity of the host

Suggested URL: /infectious-diseases-host-energy/ | Parent: Human Health and the ACE Pathway

A Complementary Question

Conventional infectious-disease treatment appropriately focuses on the infectious agent, antimicrobial drugs and immune defense. The ACE Pathway introduces an additional question: does the infected tissue have sufficient usable energy to maintain function, repair damage and participate in non-immunological defense?

This is not an argument against antimicrobial or immune-based treatment. It is a proposal that host cellular energy may be an additional determinant of outcome.

Origins of the Hypothesis

The ACE concept arose from studies of stealth-adapted virus-associated cytopathic effects in cell culture. Recovery of damaged cultures was associated with particulate and fibrous materials termed ACE pigments.

These observations led to the proposal that cells possess a non-immunological energy-dependent repair or defense mechanism.

Why Infection Raises Energy Demand

Infection can increase the work required of both individual cells and the organism. Cells may need to maintain membrane gradients, synthesize proteins and lipids, repair structures, replace damaged components and sustain specialized functions while under stress.

Accordingly, infection fits the third level of cellular energy requirement: response to adversity, adaptation and repair.

A Published Clinical Branch

Published work has described neutral-red/UV-A phototherapy observations involving herpes simplex virus (HSV), herpes zoster virus (HZV) and human papillomavirus (HPV) lesions. The reported clinical observations were interpreted as being consistent with activation of the ACE Pathway rather than solely local photodynamic destruction.

These reports are clinical observations and mechanistic interpretations; they are not substitutes for controlled trials.

Research Direction

A useful research program can separate three questions:

1. Can the reported clinical effect be reproduced?

2. Is the effect local, systemic, or both?

3. Does a measurable change in ACE-related physical or biological markers accompany the clinical response?

This approach permits the observation to be tested independently of the KELEA explanation.

Selected Published Sources

Martin WJ, Stoneburner J. Alternative Cellular Energy (ACE) Pathway Activation as the Mode of Action of Neutral Red Dye Phototherapy of Human Viruses. J Hum Virol Retrovirol. 2014;1(4):00019. DOI 10.15406/jhvrv.2014.01.00019.

https://medcraveonline.com/JHVRV/JHVRV-01-00019.php